(NYSE: BAX) Baxter International's forecast annual revenue growth rate of 2.23% is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 10.55%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.11%.
Baxter International's revenue in 2026 is $11,244,000,000.On average, 19 Wall Street analysts forecast BAX's revenue for 2026 to be $5,895,026,935,610, with the lowest BAX revenue forecast at $5,689,230,917,610, and the highest BAX revenue forecast at $6,200,119,532,295. On average, 19 Wall Street analysts forecast BAX's revenue for 2027 to be $6,025,707,407,040, with the lowest BAX revenue forecast at $5,766,918,914,405, and the highest BAX revenue forecast at $6,365,785,326,785.
In 2028, BAX is forecast to generate $6,191,373,201,530 in revenue, with the lowest revenue forecast at $5,932,584,708,895 and the highest revenue forecast at $6,532,480,101,365.